SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: James Silverman who wrote (252)1/31/1997 3:47:00 PM
From: billkirn   of 6136
 
My crystal ball says Agouron will bring approx. 100 Million
to the bottom line in 1998, and have the potential for much
greater profit with new important drugs in 1999.
Lets give this puppy a 45 PE in 1998 and, wake me up
if I am dreaming, my price target is $450 per share in June 1998.
If Roche wants to buy Agouron at a discount, maybe a current
price of $225 per share would be acceptable...

This year is going to be very exciting.....

Bill

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext